DRUGS/PRESCRIPTION: Provides relative to the prescribing, administering, and dispensing of drugs for off-label use
HB 112 allows healthcare professionals with prescriptive authority to prescribe, administer, or dispense FDA-approved drugs for off-label uses - such as different dosages, age groups, or unapproved medical conditions - without restrictions from licensing boards. It directly affects doctors, nurses, and other licensed prescribers by removing barriers to using drugs in ways not specifically FDA-approved for that purpose. The bill prohibits licensing commissions from limiting these prescribing practices, ensuring healthcare providers can make clinical decisions based on patient needs. Currently pending in the Health and Welfare Committee, the bill has not yet been voted on or passed.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 25, 2025
Last action Apr 14, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
2
Apr 14, 2025
Committee
Read by title, under the rules, referred to the Committee on Health and Welfare.
lower
Mar 25, 2025
Committee
Under the rules, provisionally referred to the Committee on Health and Welfare.
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Kathy Edmonston
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 112
Scope: LA
Hi! I can help you understand HB 112. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline